APA

Mandorfer M., Scheiner B., Stättermayer A. F., Schwabl P., Paternostro R., Bauer D., Schaefer B., Zoller H., Peck-Radosavljevic M., Trauner M., Reiberger T., Ferenci P. & Ferlitsch A. (20190925). Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension. : Alimentary pharmacology & therapeutics.

Chicago

Mandorfer M, Scheiner B, Stättermayer A F, Schwabl P, Paternostro R, Bauer D, Schaefer B, Zoller H, Peck-Radosavljevic M, Trauner M, Reiberger T, Ferenci P and Ferlitsch A. 20190925. Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension. : Alimentary pharmacology & therapeutics.

Harvard

Mandorfer M., Scheiner B., Stättermayer A. F., Schwabl P., Paternostro R., Bauer D., Schaefer B., Zoller H., Peck-Radosavljevic M., Trauner M., Reiberger T., Ferenci P. and Ferlitsch A. (20190925). Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension. : Alimentary pharmacology & therapeutics.

MLA

Mandorfer M, Scheiner B, Stättermayer A F, Schwabl P, Paternostro R, Bauer D, Schaefer B, Zoller H, Peck-Radosavljevic M, Trauner M, Reiberger T, Ferenci P and Ferlitsch A. Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension. : Alimentary pharmacology & therapeutics. 20190925.